Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 22 citing articles:

Immune-related gene SOX10 affects ferroptosis in pancreatic cancer and facilitates tumor progression by targeting CMTM7-mediated Wnt/β-catenin signaling pathway
Guixing Jiang, Bicheng Wu, Kaikai Wang, et al.
European journal of medical research (2025) Vol. 30, Iss. 1
Open Access | Times Cited: 1
Methyltransferase-like 3 modifications of RNAs: Implications for the pathology in the endocrine system
Xiaojuan Su, Yi Qu, Dezhi Mu
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024) Vol. 1870, Iss. 3, pp. 167010-167010
Closed Access | Times Cited: 6
10% carbon dioxide improves cognitive function after subarachnoid hemorrhage in rats: inhibiting neuronal apoptosis through the PI3K/AKT signaling pathway
Liuyang Tang, Daochen Wen, Zichao Huang, et al.
Medical Gas Research (2025)
Closed Access
Summary of the mechanism of ferroptosis regulated by m6A modification in cancer progression
Bin Fan, Gangxian Chen, Shu‐Yi Huang, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access
The m6A reader IGF2BP2 promotes pancreatic cancer progression through the m6A-SLC1A5-mTORC1 axis
Xi Pu, Yuting Wu, Weiguo Long, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
Cancer metastasis under the magnifying glass of epigenetics and epitranscriptomics
Maxime Janin, Verónica Dávalos, Manel Esteller
Cancer and Metastasis Reviews (2023) Vol. 42, Iss. 4, pp. 1071-1112
Open Access | Times Cited: 9
Role of m6A modification in regulating the PI3K/AKT signaling pathway in cancer
Jie Liu, Xinyu Gu, Zhenjie Guan, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 9
YTHDF2 promotes gallbladder cancer progression and gemcitabine resistance via m6A‐dependent DAPK3 degradation
Xuesong Bai, Jiemin Chen, Wen-Qin Zhang, et al.
Cancer Science (2023) Vol. 114, Iss. 11, pp. 4299-4313
Open Access | Times Cited: 8
Abnormal changes in metabolites caused by m6A methylation modification: The leading factors that induce the formation of immunosuppressive tumor microenvironment and their promising potential for clinical application
Liang Zhao, Junchen Guo, Shasha Xu, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 2
Role of RNA modifications in cancer metastasis
Nofar Malka‐Tunitsky, Aldema Sas‐Chen
Current Opinion in Genetics & Development (2024) Vol. 87, pp. 102232-102232
Closed Access | Times Cited: 2
Peptide degrader‐based targeting of METTL3/14 improves immunotherapy response in cutaneous melanoma
Hong Han, Zenghui Li, Yuqing Feng, et al.
Angewandte Chemie International Edition (2024) Vol. 63, Iss. 48
Closed Access | Times Cited: 2
Influence of RNA Methylation on Cancerous Cells: A Prospective Approach for Alteration of In Vivo Cellular Composition
Manali Rupareliya, Pravin Shende
Advances in experimental medicine and biology (2024)
Closed Access | Times Cited: 2
Lycorine inhibits pancreatic cancer cell growth and neovascularization by inducing Notch1 degradation and downregulating key vasculogenic genes
Jindan Qi, Mei Meng, Juntao Liu, et al.
Biochemical Pharmacology (2023) Vol. 217, pp. 115833-115833
Closed Access | Times Cited: 5
M6A RNA methylation in biliary tract cancer: the function roles and potential therapeutic implications
Xuesong Bai, Jianhao Huang, Yiqun Jin, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 1
YTHDF1 in Tumor Cell Metabolism: An Updated Review
Haichuan Rong, Danyang Wang, Yiran Wang, et al.
Molecules (2023) Vol. 29, Iss. 1, pp. 140-140
Open Access | Times Cited: 2
METTL3-mediated m6A modification promotes chemoresistance of intrahepatic cholangiocarcinoma by up-regulating NRF2 to inhibit ferroptosis in cisplatin-resistant cells
Xiaoping Zheng, Huiying Li, Jian Lin, et al.
Journal of Chemotherapy (2024), pp. 1-11
Closed Access
DEAD-box helicase family proteins: emerging targets in digestive system cancers and advances in targeted drug development
Xiaochao Ma, Tianyu Lu, Yue Yang, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access
The three YTHDF paralogs and VIRMA are the major tumor drivers among the m6A core genes in a pan-cancer analysis
Eliana Destefanis, Denise Sighel, Davide Dalfovo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Peptide degrader‐based targeting of METTL3/14 improves immunotherapy response in cutaneous melanoma
Hong Han, Zenghui Li, Yuqing Feng, et al.
Angewandte Chemie (2024) Vol. 136, Iss. 48
Open Access
The three YTHDF paralogs and VIRMA are strong cross-histotype tumor driver candidates among m6A core genes
Eliana Destefanis, Denise Sighel, Davide Dalfovo, et al.
NAR Cancer (2024) Vol. 6, Iss. 4
Open Access
The implications of N6-methyladenosine (m6A) modification in esophageal carcinoma
Cheng He, Xiao Teng, Luming Wang, et al.
Molecular Biology Reports (2023) Vol. 50, Iss. 10, pp. 8691-8703
Open Access | Times Cited: 1
m6A reader YTHDF1 inhibits the growth of neuroblastoma in vitro and in vivo
Jing Deng, Jun Long, Yang Yang, et al.
Research Square (Research Square) (2023)
Open Access
Page 1

Scroll to top